Skip to main content
Clinical Trials/NCT04993716
NCT04993716
Unknown
N/A

Epidemiological Study on the Management of Out-of-hospital Cardiac Arrest Survivors in Champagne ArDEnnes

Stephane Sanchez1 site in 1 country294 target enrollmentOctober 4, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Out-of-hospital Cardiac Arrest
Sponsor
Stephane Sanchez
Enrollment
294
Locations
1
Primary Endpoint
Analysis of prognostic factors associated with survival without severe neurological sequelae (CPC 1-2) at 3 months among the following variables
Last Updated
3 years ago

Overview

Brief Summary

Out-of-hospital cardiac arrest (OHCA) is a public health problem, affecting 50,000 people per year in France. Intervention time (initiation of cardiopulmonary resuscitation (CPR) and advanced CPR) are associated with a better prognosis. Despite this, the latest published data show a very low overall survival (5%). Our territory has only three centers distributed hospitals with both a 24-hour coronary angiography platform and an intensive care unit. Finally, although 60% of ACEHs receive coronary angiography in the Île de France region, it is performed on only 15% of patients in the Reims University Hospital.

Therefore, it seems essential to conduct a study on the reality of the support of ACEH and to study the clinical and biological factors as well as the influence of the geographical distribution of specialized technical platforms on the prognosis of patients.

Registry
clinicaltrials.gov
Start Date
October 4, 2021
End Date
December 31, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Stephane Sanchez
Responsible Party
Sponsor Investigator
Principal Investigator

Stephane Sanchez

Sponsor

Centre Hospitalier de Troyes

Eligibility Criteria

Inclusion Criteria

  • Patient victim of ACEH in the Champagne-Ardenne region admitted living in hospital.

Exclusion Criteria

  • patient under the age of 18

Outcomes

Primary Outcomes

Analysis of prognostic factors associated with survival without severe neurological sequelae (CPC 1-2) at 3 months among the following variables

Time Frame: 3 months

Analysis of prognostic factors associated with survival without severe neurological sequelae (CPC 1-2) with collection of a bank of biological samples, identification of clinical factors and targeted temperature control

Time Frame: 12 months

Study Sites (1)

Loading locations...

Similar Trials